Rights and permissions
About this article
Cite this article
Identifying age-specific costs of CF in The Netherlands. Pharmacoecon. Outcomes News 57, 5 (1996). https://doi.org/10.1007/BF03269914
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269914